Grey Wolf Health Corp. WOLF.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.51% | 28.49% | 30.88% | 23.96% | 16.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.51% | 28.49% | 30.88% | 23.96% | 16.21% |
| Cost of Revenue | 20.13% | 23.11% | 25.45% | 19.21% | 11.72% |
| Gross Profit | 24.65% | 33.52% | 36.03% | 28.47% | 20.56% |
| SG&A Expenses | 19.61% | 21.19% | 19.44% | 19.78% | 13.09% |
| Depreciation & Amortization | 18.36% | 35.10% | 68.22% | 64.50% | 40.34% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.81% | 22.92% | 24.81% | 21.44% | 13.59% |
| Operating Income | 49.83% | 92.33% | 104.57% | 53.73% | 51.44% |
| Income Before Tax | 58.67% | 95.37% | 67.02% | -2.92% | 12.65% |
| Income Tax Expenses | 18.04% | 14.83% | 3.57% | 8.04% | 15.28% |
| Earnings from Continuing Operations | 92.92% | 184.44% | 127.62% | -10.74% | 10.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.92% | 184.44% | 127.62% | -10.74% | 10.57% |
| EBIT | 49.83% | 92.33% | 104.57% | 53.73% | 51.44% |
| EBITDA | 36.17% | 70.73% | 90.87% | 63.35% | 53.51% |
| EPS Basic | 130.50% | 221.19% | 149.30% | -34.12% | -11.88% |
| Normalized Basic EPS | 68.68% | 95.43% | 64.58% | -19.57% | -2.15% |
| EPS Diluted | 187.16% | 326.74% | 212.73% | -47.80% | -29.22% |
| Normalized Diluted EPS | 65.93% | 92.57% | 62.50% | -21.30% | -2.15% |
| Average Basic Shares Outstanding | 9.29% | 11.87% | 14.69% | 5.06% | 2.46% |
| Average Diluted Shares Outstanding | 10.52% | 13.11% | 16.63% | 6.94% | 3.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |